社区队列中2型心肌梗死的发病率、趋势与结局
该研究前瞻性纳入2003至2012年美国明尼苏达州奥姆斯特德县居民中心肌肌钙蛋白T≥0.01 ng/mL的患者,回顾性分类为1型心肌梗死、2型心肌梗死或心肌损伤。结果显示2型心肌梗死年发病率从130/10万降至78/10万(P=0.02),与1型心肌梗死相近;2型心肌梗死后长期全因死亡率更高,主要由早期和非心血管死亡驱动。
要点
- 社区中2型心肌梗死发病率与1型心肌梗死已相近,且呈下降趋势。
- 2型心肌梗死后长期全因死亡率高于1型,但心血管死亡率相似。
- 2型心肌梗死的诱因影响预后,心律失常所致者预后较好。
核心结论
- 社区心肌梗死类型分布发生演变,2型心肌梗死发病率与1型心肌梗死相近。
- 2型心肌梗死后死亡率更高,由早期和非心血管死亡驱动。
- 供需失衡的诱因影响长期生存。
研究设计与样本
- 前瞻性招募奥姆斯特德县居民,纳入2003年1月1日至2012年12月31日期间肌钙蛋白T≥0.01 ng/mL的患者。
- 回顾性分类为1型心肌梗死、2型心肌梗死或心肌损伤,随访长期全因死亡、心血管死亡和再发心肌梗死。
- 共5460例患者至少一次肌钙蛋白T≥0.01 ng/mL,其中1型心肌梗死1365例,2型心肌梗死1054例。
主要发现
- 1型心肌梗死年发病率从202/10万降至84/10万(P<0.001)。
- 2型心肌梗死年发病率从130/10万降至78/10万(P=0.02)。
- 调整年龄和性别后,2型心肌梗死长期全因死亡率高于1型心肌梗死。
- 心血管死亡风险相似(HR 0.8,95%CI 0.7-1.0,P=0.11)。
- 2型心肌梗死后5年再发2型心肌梗死估计率为9.7%,新发1型心肌梗死为1.7%。
关键数值与推荐
- 2型心肌梗死定义为供需失衡所致,无动脉粥样血栓形成。
- 心肌损伤定义为肌钙蛋白升高但不符合心肌梗死标准。
- 2型心肌梗死诱因包括心律失常、术后状态、低血压、贫血和缺氧。
临床怎么用
- 临床中应识别2型心肌梗死的供需失衡诱因,并针对诱因管理。
- 2型心肌梗死患者需关注早期非心血管死亡风险。
- 心律失常所致2型心肌梗死预后相对较好,可据此分层。
局限性
- 研究为观察性设计,可能存在分类偏倚。
- 单中心社区队列,结果外推需谨慎。
- 回顾性分类依赖病历记录,可能遗漏部分事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 myocardial infarction (T2MI) occurs because of an acute imbalance in myocardial oxygen supply and demand in the absence of atherothrombosis. Despite being frequently encountered in clinical practice, the population-based incidence and trends remain unknown, and the long-term outcomes are incompletely characterized. METHODS: We prospectively recruited residents of Olmsted County, Minnesota, who experienced an event associated with a cardiac troponin T >99th percentile of a normal reference population (≥0.01 ng/mL) between January 1, 2003, and December 31, 2012. Events were retrospectively classified into type 1 myocardial infarction (T1MI, atherothombotic event), T2MI, or myocardial injury (troponin rise not meeting criteria for myocardial infarction [MI]) using the universal definition. Outcomes were long-term all-cause and cardiovascular mortality and recurrent MI. T2MI was further subclassified by the inciting event for supply/demand mismatch. RESULTS: A total of 5460 patients had at least one cardiac troponin T ≥0.01 ng/mL; 1365 of these patients were classified as index T1MI (age, 68.5±14.8 years; 63% male) and 1054 were classified as T2MI (age, 73.7±15.8 years; 46% male). The annual incidence of T1MI decreased markedly from 202 to 84 per 100 000 persons between 2003 and 2012 (P<0.001), whereas the incidence of T2MI declined from 130 to 78 per 100 000 persons (P=0.02). In comparison with patients with T1MI, patients with T2MI had higher long-term all-cause mortality after adjustment for age and sex, driven by early and noncardiovascular death. Rates of cardiovascular death were similar after either type of MI (hazard ratio, 0.8 [95% CI, 0.7-1.0], P=0.11). Subclassification of T2MI by cause demonstrated a more favorable prognosis when the principal provoking mechanism was arrhythmia, in comparison with postoperative status, hypotension, anemia, and hypoxia. After index T2MI, the most common MI during follow-up was a recurrent T2MI, whereas the occurrence of a new T1MI was relatively rare (estimated rates at 5 years, 9.7% and 1.7%). CONCLUSIONS: There has been an evolution in the type of MI occurring in the community over a decade, with the incidence of T2MI now being similar to T1MI. Mortality after T2MI is higher and driven by early and noncardiovascular death. The provoking mechanism of supply/demand mismatch affects long-term survival. These findings underscore the healthcare burden of T2MI and provide benchmarks for clinical trial design.
引用
- Raphael CE, Roger VL, Sandoval Y, et al. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort. Circulation. 2020. PMID: 31902228. doi:10.1161/CIRCULATIONAHA.119.043100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。